目次

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Applications
1.2.3. Technology
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Neuroprosthetics Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Target Diseases
3.2.1.2. Technological Advancements In Neuroprosthetics
3.2.1.3. Rising Number of Awareness Initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. Product Recalls
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing Number of Clinical Trials
3.2.3.2. Launches Of Novel Products
3.2.3.3. Increasing Research & Development Activities
3.2.4. Market Challenge Analysis
3.2.4.1. Shortage of Skilled Professionals
3.2.4.2. Potential Complications & Risks Associated with Neuroprosthetics
3.3. Neuroprosthetics Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. Neuroprosthetics Market: Segment Analysis, By Type, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2033
4.3. Global Neuroprosthetics Market, by Type, 2021 to 2033
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
4.4.1. Motor Prosthetics
4.4.1.1. Motor prosthetics devices market, 2021 - 2033 (USD Million)
4.4.2. Cochlear Implants
4.4.2.1. Cochlear implants market, 2021 - 2033 (USD Million)
4.4.3. Cognitive Prosthetics
4.4.3.1. Cognitive prosthetics market, 2021 - 2033 (USD Million)
4.4.4. Retinal Implants
4.4.4.1. Retinal implants market, 2021 - 2033 (USD Million)

Chapter 5. Neuroprosthetics Market: Segment Analysis, By Applications, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. Applications Market Share Analysis, 2024 & 2033
5.3. Global Neuroprosthetics Market, by Applications, 2021 to 2033
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
5.4.1. Motor Neuron Disorders
5.4.1.1. Motor neuron disorders market, 2021 - 2033 (USD Million)
5.4.1.2. Parkinson’s Disease
5.4.1.2.1. Parkinson’s disease market, 2021 - 2033 (USD Million)
5.4.1.3. Epilepsy
5.4.1.3.1. Epilepsy market, 2021 - 2033 (USD Million)
5.4.2. Physiological Disorders
5.4.2.1. Physiological disorders market, 2021 - 2033 (USD Million)
5.4.2.2. Auditory Disorders
5.4.2.2.1. Auditory disorders market, 2021 - 2033 (USD Million)
5.4.2.3. Ophthalmic Disorders
5.4.2.3.1. Ophthalmic disorders market, 2021 - 2033 (USD Million)
5.4.2.4. Cardiac Disorders
5.4.2.4.1. Cardiac disorders market, 2021 - 2033 (USD Million)
5.4.2.5. Kidney Disorders
5.4.2.5.1. Kidney disorders market, 2021 - 2033 (USD Million)
5.4.3. Cognitive Disorders
5.4.3.1. Cognitive disorders market, 2021 - 2033 (USD Million)
5.4.3.2. Alzheimer’s Disease
5.4.3.2.1. Alzheimer’s disease market, 2021 - 2033 (USD Million)
5.4.3.3. Severe Depression
5.4.3.3.1. Severe depression market, 2021 - 2033 (USD Million)

Chapter 6. Neuroprosthetics Market: Segment Analysis, By Technology, 2021 - 2033 (USD Million)
6.1. Definition and Scope
6.2. Technology Market Share Analysis, 2024 & 2033
6.3. Global Neuroprosthetics Market, by Technology, 2021 to 2033
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
6.4.1. Deep Brain Stimulation
6.4.1.1. Deep brain stimulation market, 2021 - 2033 (USD Million)
6.4.2. Vagus Nerve Stimulation
6.4.2.1. Vagus nerve stimulation market, 2021 - 2033 (USD Million)
6.4.3. Spinal Cord Stimulation
6.4.3.1. Spinal cord stimulation market, 2021 - 2033 (USD Million)
6.4.4. Sacral Nerve Stimulation
6.4.4.1. Sacral nerve stimulation market, 2021 - 2033 (USD Million)

Chapter 7. Neuroprosthetics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Global Key company market share analysis, 2024
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. LivaNova PLC
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cochlear Ltd.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Abbott
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Boston Scientific Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Nevro Corp
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Sonova
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Science Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Advanced Bionics AG
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. MED-EL Medical Electronics
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.4. Heat Map Analysis/ Company Market Position Analysis
8.5. Estimated Company Market Share Analysis, 2024
8.6. List of Other Key Market Players

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America neuroprosthetics market, by country, 2021 - 2033 (USD Million)
Table 4 North America neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 5 North America neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 6 North America neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 7 U.S. neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 8 U.S. neuroprosthetics, by application, 2021 - 2033 (USD Million)
Table 9 U.S. neuroprosthetics, by technology, 2021 - 2033 (USD Million)
Table 10 Canada neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 11 Canada neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 12 Canada neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 13 Mexico neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 14 Mexico neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 15 Mexico neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 16 Europe neuroprosthetics market, by country, 2021 - 2033 (USD Million)
Table 17 Europe neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 18 Europe neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 19 Europe neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 20 UK neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 21 UK neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 22 UK neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 23 Germany neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 24 Germany neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 25 Germany neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 26 France neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 27 France neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 28 France neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 29 Italy neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 30 Italy neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 31 Italy neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 32 Spain neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 33 Spain neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 34 Spain neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 35 Norway neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 36 Norway neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 37 Norway neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 38 Sweden neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 39 Sweden neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 40 Sweden neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 41 Denmark neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 42 Denmark neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 43 Denmark neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 44 Asia Pacific neuroprosthetics market, by country, 2021 - 2033 (USD Million)
Table 45 Asia Pacific neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 46 Asia Pacific neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 47 Asia Pacific neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 48 China neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 49 China neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 50 China neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 51 Japan neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 52 Japan neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 53 Japan neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 54 India neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 55 India neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 56 India neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 57 Australia neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 58 Australia neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 59 Australia neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 60 South Korea neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 61 South Korea neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 62 South Korea neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 63 Latin America neuroprosthetics market, by country, 2021 - 2033 (USD Million)
Table 64 Latin America neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 65 Latin America neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 66 Latin America neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 67 Brazil neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 68 Brazil neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 69 Brazil neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 70 Argentina neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 71 Argentina neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 72 Argentina neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 73 Middle East & Africa neuroprosthetics market, by country, 2021 - 2033 (USD Million)
Table 74 Middle East & Africa neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 75 Middle East & Africa neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 76 Middle East & Africa neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 77 South Africa neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 78 South Africa neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 79 South Africa neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 80 Saudi Arabia neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 81 Saudi Arabia neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 82 Saudi Arabia neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 83 UAE neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 84 UAE neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 85 UAE neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
Table 86 Kuwait neuroprosthetics market, by type, 2021 - 2033 (USD Million)
Table 87 Kuwait neuroprosthetics market, by application, 2021 - 2033 (USD Million)
Table 88 Kuwait neuroprosthetics market, by technology, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Index of Figures
Fig. 2 Neuroprosthetics market segmentation
Fig. 3 Market research process
Fig. 4 Information procurement
Fig. 5 Primary research pattern
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Market outlook (2024)
Fig. 11 Segment Outlook
Fig. 12 Strategy framework
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Neuroprosthetics market: Type movement analysis
Fig. 19 Neuroprosthetics market type outlook: Key takeaways
Fig. 20 Motor prosthetics market, 2021 - 2033 (USD Million)
Fig. 21 Cochlear implants market, 2021 - 2033 (USD Million)
Fig. 22 Cognitive prosthetics market, 2021 - 2033 (USD Million)
Fig. 23 Retinal implants market, 2021 - 2033 (USD Million)
Fig. 24 Neuroprosthetics market: Technology movement analysis
Fig. 25 Neuroprosthetics market Technology outlook: Key takeaways
Fig. 26 Deep brain stimulation market, 2021 - 2033 (USD Million)
Fig. 27 Vagus nerve stimulation market, 2021 - 2033 (USD Million)
Fig. 28 Spinal cord stimulation market, 2021 - 2033 (USD Million)
Fig. 29 Sacral nerve stimulation market, 2021 - 2033 (USD Million)
Fig. 30 Neuroprosthetics market: Application movement analysis
Fig. 31 Neuroprosthetics market Applications outlook: Key takeaways
Fig. 32 Motor neuron disorders market, 2021 - 2033 (USD Million)
Fig. 33 Parkinson’s disease market, 2021 - 2033 (USD Million)
Fig. 34 Epilepsy market, 2021 - 2033 (USD Million)
Fig. 35 Physiological disorders market, 2021 - 2033 (USD Million)
Fig. 36 Auditory disorders market, 2021 - 2033 (USD Million)
Fig. 37 Ophthalmic disorders market, 2021 - 2033 (USD Million)
Fig. 38 Cardiac disorders market, 2021 - 2033 (USD Million)
Fig. 39 Kidney disorders market, 2021 - 2033 (USD Million)
Fig. 40 Cognitive disorders market, 2021 - 2033 (USD Million)
Fig. 41 Alzheimer’s disease market, 2021 - 2033 (USD Million)
Fig. 42 Severe depression market, 2021 - 2033 (USD Million)
Fig. 43 Regional outlook, 2024 & 2033
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 46 U.S. neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 47 Canada neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 48 Europe neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 49 UK. neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 50 Germany neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 51 France neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 52 Italy neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 53 Spain neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 54 Norway neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 55 Denmark neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 56 Sweden neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 57 Asia Pacific neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 58 Japan neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 59 China neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 60 India neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 61 Australia neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 62 South Korea neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 63 Thailand neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 64 Latin America neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 65 Brazil neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 66 Mexico neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 67 Argentina neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 68 MEA neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 69 South Africa neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 70 Saudi Arabia neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 71 UAE neuroprosthetics market, 2021 - 2033 (USD Million)
Fig. 72 Kuwait neuroprosthetics market, 2021 - 2033 (USD Million)